The Surveillance Strategy for Intraductal Pancreatic Mucinous Neoplasms
Patients with stable IPMNs have similar pancreatic cancer risk as the general population. Surveillance discontinuation can be considered after 5 years in a cohort of patients, saving £106,211.19 ($136,020.42) per year.
Authors
- David Holroyd (ORCID: https://orcid.org/0000-0002-9057-3675)
- David K. Chang (ORCID: https://orcid.org/0000-0002-4821-3078)
- Maria Coats
- Andrew J. Cameron (ORCID: https://orcid.org/0000-0002-7065-9033)
- Nigel B. Jamieson (ORCID: https://orcid.org/0000-0002-9552-4725)
- Mari-Claire McGuigan (ORCID: https://orcid.org/0000-0003-0778-7582)
- Colin J. McKay
- Euan J. Dickson
- Rafaella Hadjicosti
Institutions
- Glasgow Royal Infirmary (GB)
- Pancreatic Cancer UK (GB)
- University of Glasgow (GB)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1097/sla.0000000000006580
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85